GlassScriptPhysician profile
Clifford Tillman
NPI 1053309732
$580.09
in general payments reported to CMS, 2019-2025
10 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $54.86 · 2024: $55.72 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $181.65 | 2019-2020 | |
| Boston Scientific Corporation | $157.11 | 2019-2020 | |
| Ardelyx, INC. | $60.26 | 2024-2025 | Ibsrela |
| Olympus America INC. | $48.41 | 2024-2025 | Single Use Electrosurgical Snare Sd-400, Single Use Repositionable Clip, Endoclot Phs |
| Novo Nordisk INC | $41.78 | 2025 | Wegovy |
| Qol Medical, LLC | $32.25 | 2019 | |
| Lilly USA, LLC | $15.78 | 2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $14.49 | 2020 | |
| Abbvie INC. | $14.39 | 2019 | |
| Braintree Laboratories, INC. | $13.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Tillman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.